"Tivikai" (dolutegravir): price, analogues. Where to buy Tivicai

The drug "Tivikai" is an integrase inhibitor belonging to the second generation, and is used to treat HIV. Its main active ingredient, dolutegravir, is patented by ViiV Healthcare. It is capable of binding an enzyme that catalyzes the incorporation of HIV into the chromosome of human cells. This remedy is recommended for patients who have not previously received therapy, and for those who have HAART.

Where can the drug "Tivikai" buy cheaper

The drug described is an effective tool in the fight against HIV infection. It is able to normalize the patient's condition, reduce the concentration of viral RNA in the plasma and significantly reduce the risk of complications.

But the tablets "Tivikai" price in Moscow is kept within 25 000 rubles. For packing, and since this drug will have to be taken long enough, the treatment can noticeably hit them on the patient's pocket. In early 2017, the Indian company HETERO announced the launch of the reproduction of the generic "Tivikai" under the local name "DOLUVIR" . Beginning of sales of a generic in India is a lifeline for many HIV patients whose treatment regimens have become obsolete or do not have the desired effect. Already now, for those who want to buy Tivikai at a lower price, there is an opportunity to purchase it on WWW.ARV24.NET - the site of the Indian supplier of medicines.

Here you can buy generics - funds that are issued under a license and have an identical active ingredient with the brand drug. The low cost of a generic product is explained only by the fact that for its release the company did not need to spend money on development, research and advertising company. All this, respectively, and makes it possible to profit at a much lower retail price of medicines.

Application and dosage

Tablets "Tivikai" are prescribed in combination with other drugs for the therapy of HIV-1 infection in both adult patients and children from 12 years old, with a body weight exceeding 40 kg.

The named preparation is appointed only by the expert. It is taken regardless of food. The dose recommended to patients who do not have resistance to InI is 50 mg once a day. And those who are suspected or documented, 50 mg divided into 2 doses.

If the Tivicay tablets were missed for any reason, they should be taken as soon as possible, but on condition that there are at least four hours left before the next appointment. Otherwise, it is better to wait for the next reception time according to the existing schedule.

Contraindications

Available on the drug "Tivikai" reviews describe this tool as highly effective and has a high threshold of resistance. But the purpose of this tool has its limitations. Thus, tablets are not applied in the following cases:

• Hypersensitivity to their main active ingredient (dolutegravir) or to other components of the drug;
• The need for the use of drugs containing dofetilide;
• At the age of 12 years and body weight less than 40 kg.

Carefully apply the drug in the presence of a patient with a serious disruption of the functioning of the liver.

Side effects

The undesirable effects that can occur during the reception of tablets "Tivikai " include the following:

• Diarrhea;
• Nausea, often accompanied by vomiting;
• flatulence;
• Abdominal pain (in the upper parts);
• headache;
• Bright dreams;
• Insomnia;
• Dizziness;
• Skin rash and itching;
• Increased fatigue.

Since the use of dolutegravir can cause the development of opportunistic infections or other complications, treatment with the named agent should only be performed under the strict supervision of a specialist with experience in HIV treatment.